tm logo
Trademark Search
BIOAEGIS

View On IC.GC.CA

BIOAEGIS
REGISTERED

on 24 Nov 2023

Last Applicant/ Owned by

BIOAEGIS THERAPEUTICS INC.

675 US Highway OneNorth Brunswick NJ 08902

US

Serial Number

2030792 filed on 20th Feb 2020

Registration Number

TMA1210448 registered on 24th Nov 2023

Registration expiry Date

20th Feb 2030

Correspondent Address

TD Canada Trust TowerSuite 1600421 -7 Avenue SWCalgary

ALBERTA

CA

T2P4K9

BIOAEGIS

Trademark usage description

diagnostic preparations for the treatment of inflammatory diseases and conditions, namely inflammatory bowel diseases and conditions, inflammatory con Read More

Classification Information

Class [005]
Diagnostic preparations for the treatment of inflammatory diseases and conditions, namely inflammatory bowel diseases and conditions, inflammatory connective tissue diseases and conditions, inflammatory ophthalmic diseases and conditions and inflammatory pulmonary diseases and conditions, cytokine storm, and inflammatory trauma, autoimmune diseases and conditions, and degenerative diseases and conditions, namely, Alzheimer's disease, Parkinson's disease, Huntington's disease, and multiple sclerosis, and joint degenerative diseases and disorders; Pharmaceutical preparations for the treatment of inflammatory diseases and conditions, namely inflammatory bowel diseases and conditions, inflammatory connective tissue diseases and conditions, inflammatory ophthalmic diseases and conditions and inflammatory pulmonary diseases and conditions, cytokine storm and inflammatory trauma, autoimmune diseases and disorders, degenerative diseases and disorders, namely, Alzheimer's disease, Parkinson's disease, Huntington's disease, multiple sclerosis, joint degenerative diseases and disorders, metabolic diseases and disorders and infectious diseases and disorders, namely urinary tract infections, respiratory infections, eye infections, pulmonary infections, and blood infections; Pharmaceutical preparations for the therapeutic treatment of inflammatory diseases and conditions, namely inflammatory bowel diseases and conditions, inflammatory connective tissue diseases and conditions, inflammatory ophthalmic diseases and conditions and inflammatory pulmonary diseases and conditions, cytokine storm and inflammatory trauma, autoimmune diseases and disorders, degenerative diseases and disorders, namely, Alzheimer's disease, Parkinson's disease, Huntington's disease, multiple sclerosis, joint degenerative diseases and disorders, metabolic diseases and disorders and infectious diseases and disorders, namely urinary tract infections, respiratory infections, eye infections, pulmonary infections, and blood infections.

Classification kind code

11

Class [042]
Research and development in the field of technology and diagnostics in the field of immunotherapy, inflammation, autoimmune diseases and disorders, degenerative diseases and disorders, metabolic diseases and disorders and infectious diseases and disorders; research and development in the pharmaceutical and biotechnology fields.

Classification kind code

11

Mark Details

Serial Number

2030792

Mark Type

Trademark

Legal History

Show more

Action TakenStatus
Submitted for opposition 48
on 19th Apr 2022		Agent Changed
Submitted for opposition 22
on 22nd Sep 2021		Search Recorded
Submitted for opposition 20
on 22nd Sep 2021		Examiner's First Report
Submitted for opposition 223
on 22nd Sep 2021		Total Provisional Refusal
Submitted for opposition 256
on 29th Mar 2021		Notification of Possible Opposition Sent
Submitted for opposition 257
on 28th May 2020		Designation Notification - Madrid Protocol
Submitted for opposition 1
on 27th May 2020		Created
Submitted for opposition 31
on 27th May 2020		Formalized
Submitted for opposition 30
on 20th Feb 2020		Filed
Submitted for opposition 228
on 20th Feb 2020		International Registration